KRAS and neoplasm: Also, PFS and OS were significantly shorter in patients with KRAS/STK11 co-mutant tumor than in those with KRAS mutant and STK11 wild type (KRASm/STK11wt) tumor (PFS: p < 0.001; OS: p = 0.0015) [67].